Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770497470713 Cache Key: cqdTagPageBySlug:castration-resistant-prostate-cancer fetchCache[cqdTagPageBySlug:castration-resistant-prostate-cancer].expirationTime: falsey fetchCache[cqdTagPageBySlug:castration-resistant-prostate-cancer]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: 4637 -- Key: cqdTagPageBySlug:convection-enhanced-delivery-ced, seconds remaining: -6555 -- Key: cqdPostsByTag:cqd-migrated-tag-2851,1,10, seconds remaining: -6478 -- Key: cqdTagPageBySlug:renal-artery-aneurysm, seconds remaining: -6353 -- Key: cqdPostsByTag:cqd-migrated-tag-917,1,10, seconds remaining: -6279 -- Key: cqdTagPageBySlug:medical-research, seconds remaining: -6242 -- Key: cqdPostsByTag:cqd-migrated-tag-22756,1,10, seconds remaining: -6168 -- Key: cqdTagPageBySlug:acute-patient-care, seconds remaining: -1827 -- Key: cqdPostsByTag:cqd-migrated-tag-987,1,10, seconds remaining: -1751 -- Key: cqdTagPageBySlug:rene-favaloro, seconds remaining: 1583 -- Key: cqdPostsByTag:cqd-migrated-tag-17375,1,10, seconds remaining: 1656 -- Key: cqdTagPageBySlug:rama-nanah, seconds remaining: 2630 -- Key: cqdPostsByTag:cqd-migrated-tag-26938,1,10, seconds remaining: 2694 -- Key: cqdTagPageBySlug:peyronies-disease-pd, seconds remaining: 4637 -- Key: cqdPostsByTag:cqd-migrated-tag-768,1,10, seconds remaining: 4716 -- Key: cqdTagPageBySlug:video, seconds remaining: 5818 -- Key: cqdPostsByTag:cqd-migrated-tag-105,7,10, seconds remaining: 5891 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:castration-resistant-prostate-cancer - retrieving from Sanity CCCache.dataFetchCount: 11328 Cache cleanup seconds remaining: 13445
Advertisement
Advertisement
Tag: castration-resistant prostate cancer (CRPC)
Clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer
Cleveland Clinic-developed test identifies variant of HSD3B1 gene
What's driving tumor progression is the key, says Nima Sharifi, MD
Men with the HSD3B1(1245C) variant metabolize abiraterone differently
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Rendered: Sat Feb 07 2026 20:51:10 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.
Search
